BridgeMD
New treatment option for Depression
Official title Non-invasive BCI and Application Verification for Depressed People
ClinicalTrials.gov ID: NCT06417437
What this study is testing
What is SSRI?
SSRI is an investigational medicine, given as an once-daily, being studied as a potential treatment for depression.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Major Depressive Disorder (MDD) is a serious mental illness and public health problem that poses threat to both physical and mental health. According to statistics from WHO, it is estimated that more than 350 million people worldwide suffer from depression, with a prevalence rate of 2.1% in China, which is approximately 30 million people.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older. Healthy volunteers may be eligible.
You may be able to join if
- ≥ 12 years old, male or female, right-handed, Han ethnicity
- Meets the DSM-5 diagnostic criteria for depression, with HAMD-17 scores greater than 17 and YMRS scores less than 6;
- Primary school education or above, able to understand the research content, willing to participate in this study and sign an informed consent form
You likely can't join if
- Concomitant or previous history of organic brain disease or severe traumatic brain injury, personal or family history of epilepsy;
- Severe abnormalities in heart, liver, and kidney function;
- Patients with severe physical illnesses;
- History of substance dependence or abuse (alcohol, cocaine, drugs, etc.);
- Patients with mental disorders caused by organic diseases, drug or alcohol induced mental disorders, and other mental disorders;
- Pregnancy or lactation period;
See the full eligibility criteria
- ≥ 12 years old, male or female, right-handed, Han ethnicity
- Meets the DSM-5 diagnostic criteria for depression, with HAMD-17 scores greater than 17 and YMRS scores less than 6;
- Primary school education or above, able to understand the research content, willing to participate in this study and sign an informed consent form
- Concomitant or previous history of organic brain disease or severe traumatic brain injury, personal or family history of epilepsy;
- Severe abnormalities in heart, liver, and kidney function;
- Patients with severe physical illnesses;
- History of substance dependence or abuse (alcohol, cocaine, drugs, etc.);
- Patients with mental disorders caused by organic diseases, drug or alcohol induced mental disorders, and other mental disorders;
- Pregnancy or lactation period;
- Within six months, physical therapy such as MECT and TMS should be used;
- Implants of vegetative nerve stimulation;
- Individuals who have implanted electronic or metal instruments (such as pacemakers, defibrillators, stents, orthopedic plates, etc.) and undergo ventriculoperitoneal shunt surgery;
- Obvious visual and auditory impairment, unable to cooperate in completing neuropsychological and scale assessments.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.